EQRX wants to make high-end medicines less costly

by Philippa Kaur 17 January 2020, 23:00 159 Views

A Boston-based biotech startup thinks it has found a lucrative third way between high-margin branded drugs and high-volume generics

Source: Business - economist.com

As stocks hit more and more records, there are signs traders may be getting way too euphoric

A theory on who's doing all the buying that's pushing stocks higher and higher

This portal is not a newspaper as it is updated without periodicity. It cannot be considered an editorial product pursuant to law n. 62 of 7.03.2001. The author of the portal is not responsible for the content of comments to posts, the content of the linked sites. Some texts or images included in this portal are taken from the internet and, therefore, considered to be in the public domain; if their publication is violated, the copyright will be promptly communicated via e-mail. They will be immediately removed.

EQRX wants to make high-end medicines less costly

As stocks hit more and more records, there are signs traders may be getting way too euphoric

A theory on who's doing all the buying that's pushing stocks higher and higher

ITALIAN LANGUAGE

ENGLISH LANGUAGE